Heparin Sodium Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-05-13　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 8.42 Bn
2033 年預估規模: USD 12.96 Bn
年複合成長率 CAGR: 6.4%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-05-13頁數 168報告編號 CMI9492

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Heparin Sodium Market, By Product Type (Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH)), By Source (Porcine-derived and Bovine-derived), By Route of Administration (Intravenous and Subcutaneous), By Application (Venous Thromboembolism (VTE), Atrial Fibrillation & Coronary Artery Disease, Kidney Dialysis, Surgery & Critical Care, and Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Dialysis Centers, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global heparin sodium market is estimated to be valued at USD 8.42 Bn in 2026 and is expected to reach USD 12.96 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033. Heparin sodium is an anticoagulant drug that is frequently prescribed for preventing and treating thromboembolic conditions such as deep vein thrombosis, pulmonary embolism, and acute coronary syndrome. The medicine is largely applied in the course of heart surgeries, dialysis treatment, extracorporeal circulation, and other critical care applications in order to inhibit blood clotting. Growing incidence of cardiovascular diseases, surgical procedures, and chronic kidney diseases necessitating hemodialysis therapy have become major drivers sustaining the market demand worldwide. Moreover, the increasing aged population and number of admissions into hospitals also positively influence the use of anticoagulant medications in medical institutions. In addition, developments in the manufacturing of injectable pharmaceuticals and emergence of premixed heparin products make anticoagulants more convenient and safer for patients. Manufacturers of pharmaceuticals are making efforts to increase their production capacity and enhance supply chains to meet the rising demand for anticoagulant drugs in the global market. There is also a growing importance attached to quality standards and traceability in the production process as the raw material is sourced from animals (mainly pigs). Furthermore, increased investment in health care infrastructure in developing countries, along with increased knowledge about thrombosis prevention and anticoagulation treatment before surgery, will likely create growth prospects for the heparin sodium industry in the coming years. Market Dynamics The global heparin sodium market has witnessed a significant growth due to the increasing prevalence of cardiovascular disorders, venous thromboembolism, pulmonary embolism, and chronic kidney disorders that demand anticoagulants. Heparin sodium has remained essential for use in surgeries, dialysis, catheter flush, and extracorporeal circuits because of its fast anticoagulant action and effectiveness. An increased number of patients admitted in hospitals and critical care units has made a considerable contribution in promoting the consumption of heparin sodium. Furthermore, improved healthcare infrastructure in developing nations will boost the future growth of the market. Nonetheless, a number of issues may restrict the market growth over the forecast period. The threat of negative outcomes, such as hemorrhage and heparin-induced thrombocytopenia, makes the proper dosage control essential, preventing the further development of heparin sodium market in the outpatient segment. Additionally, the high dependence of the producers on animal sources for the production of heparin sodium, especially porcine intestinal mucosa, exposes the market to supply chain risks, which include the lack of materials and price changes. Moreover, growing regulation and increasing control over the quality, safety, and transparency of drug manufacturing have put additional pressure on manufacturers in the market under analysis. Key Features of the Study • This report provides in-depth analysis of the global heparin sodium market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global heparin sodium market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Pfizer Inc., Sanofi, Baxter International Inc., B. Braun Melsungen AG, Aspen Pharmacare, LEO Pharma A/S, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi, Teva Pharmaceutical Industries Ltd., and Shenzhen Hepalink Pharmaceutical Group Co., Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global heparin sodium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heparin sodium market Market Segmentation • Product Type Insights (Revenue, USD Bn, 2021 - 2033) o Unfractionated Heparin (UFH) o Low Molecular Weight Heparin (LMWH) • Source Insights (Revenue, USD Bn, 2021 - 2033) o Porcine-derived o Bovine-derived • Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) o Intravenous o Subcutaneous • Application Insights (Revenue, USD Bn, 2021 - 2033) o Venous Thromboembolism (VTE) o Atrial Fibrillation & Coronary Artery Disease o Kidney Dialysis o Surgery & Critical Care o Others • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals o Ambulatory Surgical Centers (ASCs) o Dialysis Centers o Specialty Clinics o Others • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Pfizer Inc. o Sanofi o Baxter International Inc. o Braun Melsungen AG o Aspen Pharmacare o LEO Pharma A/S o Reddy’s Laboratories Ltd. o Fresenius Kabi o Teva Pharmaceutical Industries Ltd. o Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Heparin Sodium Market, By Product Type  Global Heparin Sodium Market, By Source  Global Heparin Sodium Market, By Route of Administration  Global Heparin Sodium Market, By Application  Global Heparin Sodium Market, By End User  Global Heparin Sodium Market, By Distribution Channel  Global Heparin Sodium Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Heparin Sodium Market, By Product Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Unfractionated Heparin (UFH)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Low Molecular Weight Heparin (LMWH)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Heparin Sodium Market, By Source, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Porcine-derived  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Bovine-derived  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Heparin Sodium Market, By Route of Administration, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Intravenous  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Subcutaneous  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Heparin Sodium Market, By Application, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Venous Thromboembolism (VTE)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Atrial Fibrillation & Coronary Artery Disease  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Kidney Dialysis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Surgery & Critical Care  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Heparin Sodium Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ambulatory Surgical Centers (ASCs)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Dialysis Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Specialty Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 9. Global Heparin Sodium Market, By Distribution Channel, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 10. Global Heparin Sodium Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 11. Competitive Landscape o Pfizer Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sanofi  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Baxter International Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Braun Melsungen AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Aspen Pharmacare  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o LEO Pharma A/S  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Reddy’s Laboratories Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Fresenius Kabi  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Teva Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Shenzhen Hepalink Pharmaceutical Group Co., Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 12. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 13. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Heparin Sodium Market' - Global forecast to 2033

提及公司

Pfizer Inc.SanofiBaxter International Inc.Braun Melsungen AGAspen PharmacareLEO Pharma A/SReddy’s Laboratories Ltd.Fresenius KabiTeva Pharmaceutical Industries Ltd.Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們